Figure 1

Overall incidence rate of adverse reactions in the three drug groups over the first 96 hours post-therapy (Alb: albendazole, DEC: diethylcarbamazine citrate, Alb + DEC: albendazole + diethylcarbamazine citrate).
Overall incidence rate of adverse reactions in the three drug groups over the first 96 hours post-therapy (Alb: albendazole, DEC: diethylcarbamazine citrate, Alb + DEC: albendazole + diethylcarbamazine citrate).